Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/8/2025

Seizure Management in Rasmussen Syndrome

Core Principles

  • Epileptic seizures affecting quality of life should be treated even with poor prognosis, but anticonvulsant therapy should not impair quality of life more than the seizures themselves, as recommended by the American Academy of Neurology 1

Medication Selection and Routes

  • Rectal diazepam should be administered as the primary option for breakthrough seizures without IV access, according to the American Epilepsy Society 2
  • Intramuscular phenobarbital may be considered when benzodiazepines cannot be given rectally due to medical or social reasons, as suggested by the American Epilepsy Society 2

Palliative Sedation for Refractory Seizures

  • Midazolam is the preferred agent for palliative sedation due to its short half-life and rapid onset, as recommended by the European Society for Medical Oncology 3, 4
  • Alternative sedatives include phenobarbital, chlorpromazine, or levomepromazine, according to the European Society for Medical Oncology 3, 4
  • Doses should be titrated to achieve comfort, not complete seizure suppression, as suggested by the European Society for Medical Oncology 3
  • For terminally ill patients in severe distress where consent cannot be obtained, provision of comfort measures (including palliative sedation if necessary) should be considered standard practice and the default strategy, as recommended by the European Society for Medical Oncology 4
  • Acknowledgment that prior treatments have not been successful, current prognosis and rationale for comfort-focused care, methods available for symptom control, and reassurance that comfort will be maintained regardless of treatment decisions should be discussed with the patient and their family, according to the European Society for Medical Oncology 4

Practical Implementation

  • Capillary blood glucose monitoring can vary from twice daily to once every 3 days depending on patient condition, as suggested by the American Diabetes Association 5
  • Continuous reassessment of symptom control is essential, with dose adjustments based on patient comfort rather than seizure frequency, according to the European Society for Medical Oncology 3
  • Unnecessary medications, diagnostic tests, and tubes should be removed, as recommended by the National Comprehensive Cancer Network 6

Family Support

  • Family members should be informed of the patient's condition, treatment options, and the shift from curative to comfort-focused goals, as suggested by the European Society for Medical Oncology 4
  • Discussion of the aims, benefits, and risks of palliative approaches should be included, according to the European Society for Medical Oncology 4, 3

Common Pitfalls to Avoid

  • Do not pursue aggressive seizure control that compromises comfort or quality of remaining life, as recommended by the American Academy of Neurology 1
  • Avoid intramuscular diazepam due to erratic absorption, as suggested by the American Epilepsy Society 2
  • Do not withhold benzodiazepines in actively seizing patients due to concerns about respiratory depression—comfort is the priority, according to the European Society for Medical Oncology 3

Route-Specific Considerations

  • Subcutaneous administration of medications can be considered as an off-label alternative, as suggested by the American Academy of Neurology 1
  • Rectal administration remains highly effective and should not be dismissed due to social concerns when patient comfort is at stake, according to the American Epilepsy Society 2